Research

Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives

Audrey Ardern-Jones^1* , Regina Kenen^2* , Elly Lynch^1,3 , Rebecca Doherty⁴ and Rosalind Eeles^4,1

¹  The Royal Marsden NHS Foundation Trust, Downs Road, Surrey, UK

²  The College of New Jersey, Department of Sociology and Anthropology, New Jersey, USA

³  Austin Hospital, Melbourne, Australia

⁴  The Institute of Cancer Research, 15 Cotswold Rd, Surrey, UK

author email corresponding author email* Contributed equally

Hereditary Cancer in Clinical Practice 2010, 8:1doi:10.1186/1897-4287-8-1

Published:	12 January 2010

Abstract

Background

Women from families with a high risk of breast or ovarian cancer in which genetic testing for mutations in the BRCA1/2 genes is inconclusive are a vulnerable and understudied group. Furthermore, there are no studies of the professional specialists who treat them - geneticists, genetic counsellors/nurses, oncologists, gynaecologists and breast surgeons.

Methods

We conducted a small qualitative study that investigated women who had developed breast cancer under the age of 45 and who had an inconclusive BRCA1/2 genetic diagnostic test (where no mutations or unclassified variants were identified). We arranged three focus groups for affected women and their close female relatives - 13 women took part. We also interviewed 12 health professionals who were involved in the care of these women.

Results

The majority of the women had a good grasp of the meaning of their own or a family member's inconclusive result, but a few indicated some misunderstanding. Most of the women in this study underwent the test for the benefit of others in the family and none mentioned that they were having the test purely for themselves. A difficult issue for sisters of affected women was whether or not to undertake prophylactic breast surgery. The professionals were sensitive to the difficulties in explaining an inconclusive result. Some felt frustrated that technology had not as yet provided them with a better tool for prediction of risk.

Conclusions

Some of the women were left with the dilemma of what decision to make regarding medical management of their cancer risk. For the most part, the professionals believed that the women should be supported in whatever management decisions they considered best, provided these decisions were based on a complete and accurate understanding of the genetic test that had taken place in the family.